Modification published on 11/16/2021
Modified on November 16, 2021 to extend the application due date to November 23, 2021.
This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Training and Technical Assistance program. The purpose of this funding is to build the capacity of ADAPs through tools and technical assistance to maximize the impact of ADAPs in improving the health outcomes of people with HIV in a changing health care environment. In collaboration with HRSA, the funded entity will provide technical assistance to RWHAP Part B recipients to strengthen ADAP administrative structures and operations, and to strengthen the capacity of ADAPs to implement and administer medication assistance and health insurance assistance programs to optimize client health outcomes. The funded entity will also be responsible for conducting an ongoing assessment of RWHAP Part B recipients’ technical assistance needs related to ADAP and adapting technical assistance to changing needs. You must clearly demonstrate that you bring the experience and expertise needed to provide technical assistance and training to the state/territory health departments’ RWHAP Part B ADAP programs. For the purposes of this program, “states/territories” include the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Collaborations via subcontracts or memoranda of understanding to secure specific expertise are encouraged. An ADAP is a state/territory-administered program authorized under Part B of the RWHAP that provides FDA-approved medications to low-income individuals with HIV disease who have limited or no coverage from private insurance, Medicaid, or Medicare. ADAP funds may also be used to purchase health insurance for eligible clients and for services that enhance access to, adherence to, and monitoring of drug treatments. Client eligibility is determined by the state or territory and includes verification of HIV status and financial and residency eligibility. ADAPs are required to recertify client eligibility at least every six months. This cooperative agreement supports the primary goals of the HIV National Strategic Plan: A Roadmap to End the HIV Epidemic (2021 – 2025).
